Kepler Capital Markets set a €34.50 ($40.12) price target on Jenoptik (ETR:JEN) in a research note issued to investors on Thursday, May 9th, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
A number of other analysts have also recently commented on JEN. Baader Bank set a €30.00 ($34.88) price objective on shares of Jenoptik and gave the company a neutral rating in a research report on Thursday, May 9th. Deutsche Bank set a €33.00 ($38.37) price objective on shares of Jenoptik and gave the company a neutral rating in a research report on Tuesday, May 7th. Warburg Research set a €33.00 ($38.37) price objective on shares of Jenoptik and gave the company a buy rating in a research report on Wednesday, February 13th. DZ Bank reaffirmed a neutral rating on shares of Jenoptik in a research note on Wednesday, February 13th. Finally, Hauck & Aufhaeuser set a €32.50 ($37.79) target price on shares of Jenoptik and gave the stock a buy rating in a research note on Wednesday, February 13th. One research analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the stock. Jenoptik presently has an average rating of Hold and a consensus price target of €31.43 ($36.54).
JEN opened at €30.40 ($35.35) on Thursday. The company has a debt-to-equity ratio of 20.32, a current ratio of 2.27 and a quick ratio of 1.46. Jenoptik has a 12 month low of €22.02 ($25.60) and a 12 month high of €39.54 ($45.98). The firm has a market capitalization of $1.74 billion and a P/E ratio of 19.87.
Jenoptik AG operates as an integrated photonics company in Germany and internationally. The company's Opticals & Life Science division develops and manufactures micro-optics for beam shaping for use in the semiconductor industry, as well as for laser material processing; and optical systems and components for information and communication, security, and defense technologies.
Featured Article: Trading Strategy Methods and Types
Receive News & Ratings for Jenoptik Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jenoptik and related companies with MarketBeat.com's FREE daily email newsletter.